Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Smith

Showing results (401-410 of 419) with videos related to

Pageof 42
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gammaP W Young, D R Buckle, B C Cantello, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2)J C Bloomer, H F Boyd, D M Hickey, et al.
JAMA|February 28, 1998
Alcohol and breast cancer in women: a pooled analysis of cohort studiesS A Smith-Warner, D Spiegelman, S S Yaun, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonistsF J Lopez, L Arias, R Chan, et al.
American Journal of Epidemiology|September 21, 2000
Pooled analysis of prospective cohort studies on height, weight, and breast cancer riskP A van den Brandt, D Spiegelman, S S Yaun, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2000
N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2H F Boyd, S C Fell, S T Flynn, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 1998
The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivitiesM V Sennitt, A J Kaumann, P Molenaar, et al.
JAMA|February 15, 2001
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studiesS A Smith-Warner, D Spiegelman, S S Yaun, et al.
British Journal of Cancer|February 24, 2006
Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studiesJ M Genkinger, D J Hunter, D Spiegelman, et al.
Pageof 42

Showing results (401-410 of 419) with videos related to

Sort By:
Pageof 42
The Journal of Pharmacology and Experimental Therapeutics|March 7, 1998
Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gammaP W Young, D R Buckle, B C Cantello, et al.
Bioorganic & Medicinal Chemistry Letters|February 18, 1999
Novel 1,2,3,4-tetrahydroisoquinolines with high affinity and selectivity for the dopamine D3 receptorN E Austin, K Y Avenell, I Boyfield, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
1-(Arylpiperazinylamidoalkyl)-pyrimidones: orally active inhibitors of lipoprotein-associated phospholipase A(2)J C Bloomer, H F Boyd, D M Hickey, et al.
JAMA|February 28, 1998
Alcohol and breast cancer in women: a pooled analysis of cohort studiesS A Smith-Warner, D Spiegelman, S S Yaun, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2003
Synthesis, pharmacology and pharmacokinetics of 3-(4-aryl-piperazin-1-ylalkyl)-uracils as uroselective alpha1A-antagonistsF J Lopez, L Arias, R Chan, et al.
American Journal of Epidemiology|September 21, 2000
Pooled analysis of prospective cohort studies on height, weight, and breast cancer riskP A van den Brandt, D Spiegelman, S S Yaun, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2000
N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2H F Boyd, S C Fell, S T Flynn, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 1998
The contribution of classical (beta1/2-) and atypical beta-adrenoceptors to the stimulation of human white adipocyte lipolysis and right atrial appendage contraction by novel beta3-adrenoceptor agonists of differing selectivitiesM V Sennitt, A J Kaumann, P Molenaar, et al.
JAMA|February 15, 2001
Intake of fruits and vegetables and risk of breast cancer: a pooled analysis of cohort studiesS A Smith-Warner, D Spiegelman, S S Yaun, et al.
British Journal of Cancer|February 24, 2006
Alcohol intake and ovarian cancer risk: a pooled analysis of 10 cohort studiesJ M Genkinger, D J Hunter, D Spiegelman, et al.
Pageof 42